Showing results (91-100 of 174) with videos related to
Sort By:
Pageof 18
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 19, 2011
Differential (18)F-FDG and 3'-deoxy-3'-(18)F-fluorothymidine PET responses to pharmacologic inhibition of the c-MET receptor in preclinical tumor modelsCarleen Cullinane, Donna S Dorow, Susan Jackson, et al.Asia-Pacific Journal of Clinical Oncology|June 26, 2024
Trends in phase 1 oncology clinical trials across Australia; Analysis of ClinicalTrials.gov 2012-2022Nadia Hitchen, Adel Shahnam, Sathya Manoharan, et al.Journal of Cancer Survivorship : Research and Practice|March 31, 2021
Living with and beyond metastatic non-small cell lung cancer: the survivorship experience for people treated with immunotherapy or targeted therapyJulia Lai-Kwon, Sarah Heynemann, Jacinthe Flore, et al.Cancer|February 17, 2016
p16-positive lymph node metastases from cutaneous head and neck squamous cell carcinoma: No association with high-risk human papillomavirus or prognosis and implications for the workup of the unknown primaryLachlan J McDowell, Richard J Young, Meredith L Johnston, et al.Cancer Immunology Research|January 31, 2018
Prognostic Significance of PD-L1+ and CD8+ Immune Cells in HPV+ Oropharyngeal Squamous Cell CarcinomaBenjamin Solomon, Richard J Young, Mathias Bressel, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 2012
Sex and SUVmax: sex-dependent prognostication in early non-small cell lung cancerZoe Wainer, Marissa G Daniels, Jason Callahan, et al.Oral Oncology|December 16, 2019
Validation and characterisation of prognostically significant PD-L1+ immune cells in HPV+ oropharyngeal squamous cell carcinomaRichard J Young, Mathias Bressel, Sandro Porceddu, et al.Prenatal Diagnosis|January 30, 2020
The utility of exome sequencing for fetal pleural effusionsAngie C Jelin, Nara Sobreira, Elizabeth Wohler, et al.Health Data Science|May 6, 2026
Diagnostic Delays in Thoracic Cancer Care: A Data-Linkage, Cohort Study between Primary Care, Hospital, and Registry DataJianrong Zhang, Maarten J IJzerman, Damien McCarthy, et al.Clinical Lung Cancer|May 5, 2024
Completion of Pembrolizumab in Advanced Non-Small Cell Lung Cancer-Real World Outcomes After Two Years of Therapy (COPILOT)Andrew Fantoni, Lydia Warburton, Benjamin Solomon, et al.Pageof 18